Vafidemstat Uses, Dosage, Side Effects and more
Vafidemstat is under investigation in clinical trial NCT03867253 (Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease).
| Attribute | Details |
|---|---|
| Trade Name | Vafidemstat |
| Generic | Vafidemstat |
| Vafidemstat Other Names | Vafidemstat |
| Type | |
| Formula | C19H20N4O2 |
| Weight | Average: 336.395 Monoisotopic: 336.1586259 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Vafidemstat works
Vafidemstat is a small molecule irreversible inhibitor of histone demethylase LSD1 and also a dual inhibitor of LSD1/MAO-B.
